Discover and read the best of Twitter Threads about #Fellows2023
Most recents (2)
As someone just getting started in IC, this talk by @jaygirimd was inspiring. #VTE/#PERT is such an exciting space with rapid development & study 🙌🏽
(Also shoutout to my mentor @GoldbergJBCTMD who’s work is displayed in Dr Giri’s slides)
My takeaways, a🧵:
(1/6)
#Fellows2023
(Also shoutout to my mentor @GoldbergJBCTMD who’s work is displayed in Dr Giri’s slides)
My takeaways, a🧵:
(1/6)
#Fellows2023
🔹Risk stratification and patient selection is key.
🔸Risk scores may not accurately stratify younger patients
🔹Full risk assessment has to include with the bedside eval w/ imaging + lab markers as adjunctive data
🔸Be on the lookout for normotensive shock
#Fellows2023 (2/6)
🔸Risk scores may not accurately stratify younger patients
🔹Full risk assessment has to include with the bedside eval w/ imaging + lab markers as adjunctive data
🔸Be on the lookout for normotensive shock
#Fellows2023 (2/6)
🔹Patients can be sick - upfront MCS with ECMO may be the first treatment needed in tackling high risk PE
🔸Contralateral arterial access during thrombectomy in case urgent MCS is needed
🔹always start with a RHC to establish severity of disease
#Fellows2023 (3/6)
🔸Contralateral arterial access during thrombectomy in case urgent MCS is needed
🔹always start with a RHC to establish severity of disease
#Fellows2023 (3/6)
@djc795 with his top 10 historical #IC trials to know; studies that have had fundamental impact on the field
(Note, this is a summary, but really was a lecture to attend in person. Phenomenal & super fun)
@rwyeh @nadia_sutton @DougDrachmanMD @SrihariNaiduMD
A thread🧵:
(1/6)
(Note, this is a summary, but really was a lecture to attend in person. Phenomenal & super fun)
@rwyeh @nadia_sutton @DougDrachmanMD @SrihariNaiduMD
A thread🧵:
(1/6)
1️⃣ ACME & RITA2 - SIHD, randomized PCI v meds -> ⬇️angina (CCS class)
2️⃣ BOAT - directional atherectomy, “bigger is better”. Luminal gain is🤴🏼.
3️⃣ BARI & FREEDOM - angioplasty vs CABG, important interaction of diabetes; LIMA is 🔑
#Fellows2023 @crfheart
(2/6)
2️⃣ BOAT - directional atherectomy, “bigger is better”. Luminal gain is🤴🏼.
3️⃣ BARI & FREEDOM - angioplasty vs CABG, important interaction of diabetes; LIMA is 🔑
#Fellows2023 @crfheart
(2/6)
4️⃣ PAMI - PTCA v tPA, significantly ⬇️death/MI, 🚫ICH w/ PTCA
5️⃣ STRESS, Benestent 1&2 - angioplasty vs stenting, showed ⬇️ in binary restenosis and ⬆️ luminal gain w/ stenting. Also, design of monitoring w/ meds v. rpt PTCA on f/u impacts modern trial design
#Fellows2023
(3/6)
5️⃣ STRESS, Benestent 1&2 - angioplasty vs stenting, showed ⬇️ in binary restenosis and ⬆️ luminal gain w/ stenting. Also, design of monitoring w/ meds v. rpt PTCA on f/u impacts modern trial design
#Fellows2023
(3/6)
